FDA Approves Beyfortus for Use in Infants With RSV

Beyfortus, which can help prevent respiratory syncytial virus (RSV) in infants and toddlers, was approved by the FDA on July 17.

Related Keywords

United States ,John Farley ,Office Of Infectious Diseases ,Infectious Diseases ,Drug Evaluation ,Rsv ,Beyfortus ,Infants ,Prevent ,